PSYENCE GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 CAD | +20.00% |
|
+20.00% | -40.00% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 16.11M 22.02M 1.34B |
|---|---|---|---|---|---|
| Net income 2022 | -4M -5.47M -334M | Net income 2023 | -6M -8.2M -500M | EV / Sales 2022 | - |
| Net cash position 2022 | 2.17M 2.96M 181M | Net cash position 2023 | 2.34M 3.19M 195M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.86
x | P/E ratio 2023 |
-1.9
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.15% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +20.00% | ||
| 1 week | +20.00% | ||
| 1 month | -14.29% | ||
| 3 months | -53.85% | ||
| 6 months | -33.33% | ||
| Current year | -40.00% |
1 week
0.02
0.03
1 month
0.020.04
Current year
0.020.08
1 year
0.020.15
3 years
0.010.36
5 years
0.010.62
10 years
0.010.62
| Managers | Title | Age | Since |
|---|---|---|---|
Jody Aufrichtig
FOU | Founder | 51 | 26/94/26 |
Katherine Murphy
IRC | Investor Relations Contact | - | - |
Taryn Vos
LAW | General Counsel | - | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Alan Friedman
BRD | Director/Board Member | 52 | 03/21/03 |
Jody Aufrichtig
FOU | Founder | 51 | 26/94/26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/24/22 | 0.03 | +20.00% | 291,000 |
Delayed Quote Canadian Securities Exchange, April 23, 2024 at 01:13 am IST
More quotes
Psyence Group Inc. is a Canada-based life science biotechnology company with a focus on natural psychedelics. The Company is focused on the research, cultivation and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. It cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at its federally licensed ISO22000 facility in Southern Africa. The Companyâs divisions include Psyence Production, Psyence Therapeutics and Psyence Function. Psyence Therapeutics develops natural psilocybin products, medicinal formulations and treatment protocols to treat mental health disorders in a clinical environment. Psyence Production operates federally licensed ISO22000 certified psilocybin cultivation and production facilities in the world. Psyence Function is focused on the development, distribution and sale of over-the-counter functional mushroom nutraceutical products.
Calendar
07/06/2024
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -40.00% | 3.05M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- PSYG Stock
